Cargando…
High hopes for cannabinoid agonists in the treatment of rheumatic diseases
There are two well-characterised isoforms of cannabinoid receptor; CB(1) and CB(2) and of these CB(2) is under active investigation as a potential target for treatment of the chronic pain associated with widespread and intractable joint diseases osteoarthritis and rheumatoid arthritis. The recent re...
Autores principales: | Staunton, Caroline A, Mobasheri, Ali, Barrett-Jolley, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289380/ https://www.ncbi.nlm.nih.gov/pubmed/25477254 http://dx.doi.org/10.1186/1471-2474-15-410 |
Ejemplares similares
-
Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases
por: Gonen, Tal, et al.
Publicado: (2020) -
Aquaporin Water Channels in the Mammary Gland: From Physiology to Pathophysiology and Neoplasia
por: Mobasheri, Ali, et al.
Publicado: (2013) -
Hope for new antibiotics for syphilis treatment
por: Stamm, Lola V.
Publicado: (2021) -
Systemic application of the transient receptor potential vanilloid-type 4 antagonist GSK2193874 induces tail vasodilation in a mouse model of thermoregulation
por: O'Brien, Fiona, et al.
Publicado: (2022) -
Intracranial Glioblastomas: New Hope for an Effective Treatment
por: Cooper, Arthur J.L.
Publicado: (2015)